Protein may hold key to restoring treatment response in drug-resistant neuroendocrine prostate cancer

It may be possible to restore drug-resistant neuroendocrine prostate cancer to a state that responds to treatment by depletion of a certain protein in cancer cells.

Primary Care Follow-Up After Emergency Surgery Tied to Fewer Readmissions

Among patients hospitalized for an emergency general surgery (EGS) condition, primary care follow-up within 30 days of discharge was associated with a significant reduction in

September 28, 2023

New Approach to Treating Melanoma

An international research team, led by Professor Wenbo Bu of Fudan University and Distinguished Professor Dayong Jin of the University of Technology Sydney, have discovered

June 20, 2024

Ukrainian researcher develops digital tool for detecting autism and developmental delay in kids

A Ukrainian researcher has developed a new digital tool for detecting autism and developmental delay in children. Her research has been published in Cambridge University

October 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.